Abstract
Background: Induced pluripotent stem cells hold tremendous potential for biological and therapeutic applications. The development of efficient technologies for targeted genome alteration of stem cells in disease models is a prerequisite for utilizing stem cells to their full potential. The revolutionary technology for genome editing known as the clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein 9 (Cas9) system is recently recognized as a powerful tool for editing DNA at specific loci.
Objective: The ease of use of the CRISPR-Cas9 technology will allow us to improve our understanding of genomic variation in disease processes via cellular and animal models. More recently, this system was modified to repress (CRISPR interference, CRISPRi) or activate (CRISPR activation, CRISPRa) gene expression without alterations in the DNA, which amplified the scope of applications of CRISPR systems for stem cell biology.
Results and Conclusion: Here, we highlight latest advances of CRISPR-associated applications in human pluripotent stem cells. The challenges and future prospects of CRISPR-based systems for human research are also discussed.
Keywords: CRISPR/Cas9, CRISPRi, CRISPRa, pluripotent stem cells, iPSC, therapy.
Current Stem Cell Research & Therapy
Title:CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells
Volume: 13 Issue: 4
Author(s): Yanli Zhang, Danuta Sastre and Feng Wang*
Affiliation:
- College of Animal Science, Nanjing Agricultural University, Nanjing,China
Keywords: CRISPR/Cas9, CRISPRi, CRISPRa, pluripotent stem cells, iPSC, therapy.
Abstract: Background: Induced pluripotent stem cells hold tremendous potential for biological and therapeutic applications. The development of efficient technologies for targeted genome alteration of stem cells in disease models is a prerequisite for utilizing stem cells to their full potential. The revolutionary technology for genome editing known as the clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein 9 (Cas9) system is recently recognized as a powerful tool for editing DNA at specific loci.
Objective: The ease of use of the CRISPR-Cas9 technology will allow us to improve our understanding of genomic variation in disease processes via cellular and animal models. More recently, this system was modified to repress (CRISPR interference, CRISPRi) or activate (CRISPR activation, CRISPRa) gene expression without alterations in the DNA, which amplified the scope of applications of CRISPR systems for stem cell biology.
Results and Conclusion: Here, we highlight latest advances of CRISPR-associated applications in human pluripotent stem cells. The challenges and future prospects of CRISPR-based systems for human research are also discussed.
Export Options
About this article
Cite this article as:
Zhang Yanli , Sastre Danuta and Wang Feng *, CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells, Current Stem Cell Research & Therapy 2018; 13 (4) . https://dx.doi.org/10.2174/1574888X13666180214124800
DOI https://dx.doi.org/10.2174/1574888X13666180214124800 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Identify Compounds' Target Against Alzheimer's Disease Based on In-Silico Approach
Current Alzheimer Research UDP-Glucuronosyltransferases
Current Drug Metabolism Personalised Genetic Intervention for Duchenne Muscular Dystrophy: Antisense Oligomers and Exon Skipping
Current Molecular Pharmacology The Use of Computational Methods in the Discovery and Design of Kinase Inhibitors
Current Pharmaceutical Design Olanzapine vs Aripiprazole in the Management of Borderline Personality Disorder
Current Psychopharmacology Editorial [Hot Topic: Regulation of Brain Functions by Adenosine A2A Receptors:Implication for Therapeutics (Executive Editor: Patrizia Popoli) ]
Current Pharmaceutical Design Advanced Glycation End Products as Environmental Risk Factors for the Development of Type 1 Diabetes
Current Drug Targets Natural Monophenols as Therapeutics, Antioxidants and Toxins; Electron Transfer, Radicals and Oxidative Stress
The Natural Products Journal Can Environmentally Relevant Levels of Aluminium Promote the Onset and Progression of Neurodegenerative Diseases?
Current Inorganic Chemistry (Discontinued) Glutamate and Schizophrenia: Pathophysiology and Therapeutics
Current Medicinal Chemistry - Central Nervous System Agents The SNPs within 3'UTR of miRNA Target Genes Related to Multiple Sclerosis: A Computational Prediction
Current Pharmacogenomics and Personalized Medicine Agroecological Strategies for Arthropod Pest Management in Brazil
Recent Patents on Food, Nutrition & Agriculture The Role of Neuronal Insulin/Insulin-Like Growth Factor-1 Signaling for the Pathogenesis of Alzheimer’s Disease: Possible Therapeutic Implications
CNS & Neurological Disorders - Drug Targets Hepatic Effects of Duloxetine – III: Analysis of Hepatic Events Using External Data Sources
Current Drug Safety Patent Selections
Recent Patents on Biomarkers Neprilysin and Amyloid Beta Peptide Degradation
Current Alzheimer Research Dysfunction in Brain-Derived Neurotrophic Factor Signaling Pathway and Susceptibility to Schizophrenia, Parkinson’s and Alzheimer’s Diseases
Current Gene Therapy MiR-34a Inhibits Spinal Cord Injury and Blocks Spinal Cord Neuron Apoptosis by Activating Phatidylinositol 3-kinase (PI3K)/AKT Pathway Through Targeting CD47
Current Neurovascular Research Oxidative Stress: The Old Enemy in Alzheimers Disease Pathophysiology
Current Alzheimer Research Preface
Adolescent Psychiatry